Left Lobe Versus Right Lobe in Adult Living Donor Liver Transplantation in Borderline GRWR (LDLT)

August 3, 2024 updated by: Ain Shams University

Left Lobe Versus Right Lobe in Adult Living Donor Liver Transplantation in Borderline GRWR: Prospective Cohort Study

a prospective cohort study comparing outcomes of left lobe and right lobe adult living donor liver transplantation

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients presented to our center for LDLT

Description

Inclusion Criteria:

  • GRWR below 1

Exclusion Criteria:

  • patients with renal impairment portal vein thrombosis vascular complications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
right lobe
cases underwent LDLT for right lobe with borderline GRWR
left lobe
cases underwent LDLT for left lobe with borderline GRWR

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
small for size syndrome
Time Frame: 1 year
small for size syndrome
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
other complications after LDLT
Time Frame: 1 year
other complications after LDLT
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ain Shams University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 15, 2024

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

June 15, 2026

Study Registration Dates

First Submitted

August 3, 2024

First Submitted That Met QC Criteria

August 3, 2024

First Posted (Actual)

August 7, 2024

Study Record Updates

Last Update Posted (Actual)

August 7, 2024

Last Update Submitted That Met QC Criteria

August 3, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ltvsrtldlt
  • Ain Shams University (Registry Identifier: passant abdalla)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Transplant; Complications

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe